Allergan, Inc. (NYSE:AGN) announced the U.S. Food and Drug Administration's (FDA) approval of JUVEDERM(R) XC, a new formulation of the currently FDA-approved JUVEDERM(R) dermal filler and the latest advancement1 in hyaluronic acid (HA) dermal fillers. Allergan's new JUVEDERM(R) formulation contains the local anesthetic lidocaine to provide patients with enhanced comfort during treatment of moderate to severe facial wrinkles and folds, such as the nasolabial folds (or "parentheses") that appear around the nose and mouth. JUVEDERM(R) is the first and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment2 and number-one selling hyaluronic acid dermal filler.
Palomar Medical Technologies, Inc. is pleased to announce that the Lux1540™ Fractional non-ablative laser handpiece has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretch marks) using a fractional laser. This new clearance will allow aesthetic practitioners to treat the millions of women worldwide who have unwanted stretch marks. Ongoing clinical studies have shown that subjects treated with the Lux1540 achieved an average improvement of between 51% and 75% in the appearance of their striae, based upon a blinded review of photographs comparing the pre-treatment appearance of striae versus the results three months post-treatment.
AcademyHealth recognized research that improves patient safety and surgical outcomes with the 2010 Health Services Research (HSR) Impact Award. The WHO Surgical Safety Checklist was created as a tool to ensure adherence to basic safety standards of care. "With this award AcademyHealth recognizes research that clearly translated into policy and, ultimately, made our health care system better, " said AcademyHealth President W. David Helms, Ph.D. "The WHO Surgical Safety Checklist exemplifies how health services research can inform the decision making process and ultimately impact the lives of Americans in a positive and beneficial manner." In 2006 the World Health Organization asked Dr.
Grant C. Jaquith, Temporary Acting United States Attorney for the Northern District of New York, and Mark Dragonetti, Special Agent-in-Charge of the Food and Drug Administration, Office of Criminal Investigations, New York Field Office, announced that The Plastic Surgery Group, LLP (TPSG) of Albany, New York, was sentenced and ordered to pay restitution in the amount of $106, 686, and a fine of $200, 000, in connection with TPSG's plea of guilty to one felony count of misbranding drugs, in violation of Title 21, United States Code, Sections 331(k), 352(i)(3), and 333(a)(2). TPSG was sentenced in Federal District Court in Albany, New York by District Judge Thomas J.
Clinical Study: Biologic Grafts Reduce Postoperative Pain While Creating A Repair As Durable As Synthetic Mesh In Treating Inguinal Hernias
Results from a clinical study led by Luca Ansaloni, M.D., showed that Cook Medical's Biodesign Inguinal Hernia Graft causes less postoperative pain and discomfort while creating a repair as durable as synthetic mesh when used in Lichtenstein's hernioplasty procedures. As published in a recent issue of the American Journal of Surgery, the three-year, 70-patient study determined that patients treated with Biodesign Inguinal Hernia Graft experienced a lower level of postoperative pain as compared with synthetic mesh-based procedures. The randomized, double-blind inguinal hernia study examined the efficacy of the Biodesign Inguinal Hernia Graft in treating 35 men compared to 35 men treated with synthetic mesh.
Bariatric weight-loss surgery may sound dangerous and complicated, but a Geisinger physician warns that the real danger may be a life of obesity. "There are risks associated with bariatric surgery, as there are with any surgical procedure, but the risks associated with the procedure may pale in comparison to the health complications that can be caused by obesity, " said Christopher Still, D.O., director of the Geisinger Center for Nutrition and Weight Management. Bariatric surgery is a weight-loss procedure that can help obese individuals significantly reduce their body weight and can improve a patient's overall health. Obesity can lead to a variety of complications including sleep apnea, diabetes, fatty liver disease, and heart disease, all of which require medical attention, Dr.